The ROE as of November 2024 (TTM) for Actinium Pharmaceuticals, Inc. (ATNM) is -101.69%

According to Actinium Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -101.69%. This represents a change of 299.74% compared to the average of -25.44% of the last 4 quarters.

Actinium Pharmaceuticals, Inc. (ATNM) Historical ROE (quarterly & annually)

How has ATNM ROE performed in the past?

The mean historical ROE of Actinium Pharmaceuticals, Inc. over the last ten years is -4.61%. The current -101.69% ROE has changed 2.11% with respect to the historical average. Over the past ten years (40 quarters), ATNM's ROE was at its highest in in the December 2014 quarter at 282.24%. The ROE was at its lowest in in the September 2014 quarter at -256.21%.

Actinium Pharmaceuticals, Inc. (ATNM) ROE by Quarter and Year

Discovering the peaks and valleys of Actinium Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Actinium Pharmaceuticals, Inc. (ATNM) Average ROE

How has ATNM ROE performed in the past?

The current ROE of Actinium Pharmaceuticals, Inc. (ATNM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Actinium Pharmaceuticals, Inc. (ATNM) ROE vs. Peers

How is ATNM’s ROE compared to its peers?

Actinium Pharmaceuticals, Inc.’s ROE is less than MiNK Therapeutics, Inc. (99.78%), greater than Affimed N.V. (-155.57%), greater than ImmunoGen, Inc. (-21.97%), greater than Adaptimmune Therapeutics plc (-117.47%), greater than Sangamo Therapeutics, Inc. (-334.92%), less than Rigel Pharmaceuticals, Inc. (46.64%), greater than Fortress Biotech, Inc. (-226.63%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), less than CTI BioPharma Corp. (180.42%), greater than Ocuphire Pharma, Inc. (-30.19%), less than Annovis Bio, Inc. (2.78%), greater than Cassava Sciences, Inc. (-10.98%), greater than Axsome Therapeutics, Inc. (-174.48%), less than Seres Therapeutics, Inc. (313.56%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Eyenovia, Inc. (-615.55%), greater than Cognition Therapeutics, Inc. (-118.11%), greater than TransCode Therapeutics, Inc. (-597.47%), greater than Kodiak Sciences Inc. (-77.23%), less than Exelixis, Inc. (21.26%), greater than TG Therapeutics, Inc. (-38.21%), greater than Viking Therapeutics, Inc. (-12.73%), greater than Madrigal Pharmaceuticals, Inc. (-71.78%), less than BioXcel Therapeutics, Inc. (176.93%),

Build a custom stock screener for Actinium Pharmaceuticals, Inc. (ATNM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinium Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Actinium Pharmaceuticals, Inc. (ATNM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Actinium Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.